XML 144 R123.htm IDEA: XBRL DOCUMENT v3.8.0.1
Quarterly Financial Information (Unaudited) (Schedule of Quarterly Financial Information) (Details)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2017
USD ($)
$ / shares
shares
Sep. 30, 2017
USD ($)
$ / shares
shares
Jun. 30, 2017
USD ($)
$ / shares
shares
Mar. 31, 2017
USD ($)
$ / shares
shares
Dec. 31, 2016
USD ($)
$ / shares
shares
Sep. 30, 2016
USD ($)
$ / shares
shares
Jun. 30, 2016
USD ($)
$ / shares
shares
Mar. 31, 2016
USD ($)
$ / shares
shares
Dec. 31, 2017
USD ($)
$ / shares
shares
Dec. 31, 2016
USD ($)
$ / shares
shares
Dec. 31, 2015
USD ($)
$ / shares
shares
Quarterly Financial Information Disclosure [Abstract]                      
Total Net Revenues | $ $ 2,242 $ 2,165 $ 2,130 $ 2,081 $ 1,972 $ 1,914 $ 1,828 $ 1,764 $ 8,618 $ 7,478 $ 6,380
Total Expenses Excluding Interest | $ 1,289 1,220 1,221 1,238 1,148 1,120 1,108 1,109 4,968 4,485 4,101
Net Income | $ 597 618 575 564 522 503 452 412 2,354 1,889 1,447
Net Income Available to Common Stockholders | $ $ 550 $ 575 $ 530 $ 525 $ 478 $ 470 $ 406 $ 392 $ 2,180 $ 1,746 $ 1,364
Weighted Average Common Shares Outstanding - Basic (in shares) | shares 1,343 1,339 1,338 1,336 1,329 1,324 1,322 1,321 1,339 1,324 1,315
Weighted Average Common Shares Outstanding - Diluted (in shares) | shares 1,358 1,353 1,351 1,351 1,341 1,334 1,333 1,330 1,353 [1] 1,334 [1] 1,327 [1]
Basic (USD per share) $ 0.41 $ 0.43 $ 0.40 $ 0.39 $ 0.36 $ 0.36 $ 0.31 $ 0.30 $ 1.63 $ 1.32 $ 1.04
Diluted (USD per share) 0.41 0.42 0.39 0.39 0.36 0.35 0.30 0.29 1.61 1.31 1.03
Dividends Declared Per Common Share (USD per share) 0.08 0.08 0.08 0.08 0.07 0.07 0.07 0.06 $ 0.32 $ 0.27 $ 0.24
Range of Common Stock Price Per Share:                      
High (USD per share) 52.52 44.35 44.10 43.65 40.58 31.87 31.07 32.23      
Low (USD per share) $ 42.20 $ 38.06 $ 37.16 $ 37.62 $ 30.66 $ 23.83 $ 24.02 $ 21.51      
Range of Price/Earnings Ratio:                      
High 33 28 30 31 31 26 27 29      
Low 26 24 25 27 24 20 21 20      
[1] Antidilutive stock options and restricted stock units excluded from the calculation of diluted EPS totaled 15 million, 26 million, and 23 million shares in 2017, 2016, and 2015, respectively.